Gapping down
In reaction to earnings/guidance:
- DPZ -4.7%, ETWO -4%, CMC -3%, KIDS -2.4% (guides Q3 revs slightly below consensus)
Other news:
- KOS -3.7% (announces 37.5 share offering; acquires additional Ghana interests for $550 mln)
- SRPT -0.6% (prices offering of 6172840 shares of its common stock at $81.00 per share)
- GRPN -0.5% (CFO resigns)
Analyst comments:
- CAR -4.1% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- BBBY -2.4% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- CTS -1.4% (downgraded to Market Perform from Outperform at Cowen)
- ESPR -1.4% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- AIRG -0.8% (downgraded to Market Perform from Outperform at Cowen )
- ACAD -0.7% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- BURL -0.7% (downgraded to Hold from Buy at Loop Capital)
Gapping up
In reaction to earnings/guidance:
- TSM +3.8%, UNH +2.7%, BAC +2.2%, WBA +1.8%, WFC +1.7%, MS +1.7%
Other news:
- NRXP +40.7% (announces the publication of results from trial of aviptadil for the treatment of respiratory failure in patients with Critical COVID-19)
- GMED +8.7% (files patent infringement lawsuit against Life Spine)
- STRL +6.8% (wins $40.4 mln aviation project at Utah airport)
- WDFC +4.8% (approves new $75 mln share repurchase authorization)
- HYZN +4.4% (expects capacity at its European facility to increase to up to 1000 trucks per year in 2022)
- BCLI +4.1% (Phase 2 Clinical Trial Data of NurOwn in Progressive MS Will Be Presented at the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis)
- VET +2.7% (achieves certification under the EO100 standard for three natural gas sites in Canada)
- SVM +2.4% (to acquire Kaunping silver-lead-zinc-gold project in China for $13.5 mln)
- FBIO +2.3% (reports clinical data for CUTX-101 at American Academy of Pediatrics National Conference & Exhibition)
- OXY +2% (to sell interests in Ghana offshore fields for $750 mln)
- TPTX +1.7% (announces collaboration with EQRx)
- NGD +1.5% (reports operational results for Q3)
- FTI +1.4% (completes acquisition of Magma Global)
- WGO +1.1% (authorizes $200 mln share repurchase authorization)
- MTRX +1% (awarded multiple contracts worth $50 mln for electrical infrastructure work)
- GOLD +1% (set to achieve 2021 production targets)
- LULU +0.9% (gets into footwear with a new design according to Business Insider)
- CNK +0.9% (names new CFO)
Analyst comments:
- DK +5.3% (upgraded to Buy from Neutral at Goldman)
- E +1.5% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)
After Hours Summary: Quiet after hours; WDFC +2.4% on share repurchase authorization; HYZN +6.7% trades upon capacity increase; GRPN down -1.4% as CFO resignsAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: None
Companies trading higher in after hours in reaction to news: HYZN +6.7% (expects capacity at its European facility to increase to up to 1,000 trucks per year in 2022), WDFC +2.4% (approves new $75 mln share repurchase authorization), SVM +1.7% (to acquire Kaunping silver-lead-zinc-gold project in China for $13.5 mln), NGD +1.5% (reports operational results for Q3), TPTX +1% (announces collaboration with EQRx), A +1% (receives companion diagnostic approval from FDA for Ki-67 IHC MIB-1 in high-risk early breast cancer), WGO +0.9% (authorizes $200 mln share repurchase authorization), GMED +0.1% (files patent infringement lawsuit against Life Spine)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: ETWO -2.5%, KIDS -2.4% (guides Q3 revs slightly below consensus)
Companies trading lower in after hours in reaction to news: KOS -4.9% (announces 37.5 share offering; acquires additional Ghana interests for $550 mln), GRPN -1.4% (CFO resigns), RMBS -0.7% (CFO to resign; co reaffirms previously issued guidance for Q3), CNHI -0.1% (to temporarily close several manufacturing facilities due to shortages of core components)
- Symrise (SY1 TH) +1.8%
- Arkema, BASF Among Buys as Jefferies Restarts Chemicals Coverage
- Vodafone (VODI TH) +1.7%
- Nibe (NJB TH) +1.6%
- HeidelbergCement (HEI TH) +1.2%
- ArcelorMittal (ARRD TH) +1.2%
- ArcelorMittal Raised to Outperform at Credit Suisse on Valuation
- Telenor (TEQ TH) +1.2%
- Bank of Ireland (BIRG TH) +1.1%
- Sartorius (SRT3 TH) +1.1%
- Akzo Nobel (AKU1 TH) -0.6%
- Arkema, BASF Among Buys as Jefferies Restarts Chemicals Coverage
- Michelin (MCH TH) -0.7%
- Siemens Gamesa (GTQ1 TH) -0.9%
- RELX (RDEB TH) -1.3%
- Zalando (ZAL TH) -1.4%
Gapping down
In reaction to earnings/guidance:
- STIM -23.4% (lowers Q3 guidance, issues downside FY21 guidance), VOXX -6.8%, CTSO -4.2% (issues downside Q3 revenue guidance; also receives full FDA IDE approval to begin US STAR-D trial)
Other news:
- SRPT -6.4% (announces $500 mln stock offering; also provides Q3 product revenue guidance)
- NAPA -6.2% (stock offering)
- CRSP -6% (announces positive results from Phase 1 CARBON Trial of CTX110)
- EFC -3.9% (prices offering of 5 mln shares of common stock for gross proceeds of $91.3 mln)
- WFG -3.2% (to acquire Angelina Forest Products lumber mill for $300 mln)
- SWKS -2.6% (Apple reportedly to cut production on iPhone production targets)
- SYBX -2.5% (announces publication of preclinical research demonstrating novel application of Synthetic Biotic platform)
- RNR -2.2% (estimates Q3 catastrophic losses at $725 mln)
- CME -2.1% (reports monthly ADV)
- SBRA -2% (prices offering 6.8 mln shares of common stock for gross proceeds of $98.9 mln)
- PYCR -2% (stock offering)
- SNCY -1.9% (stock offering)
- QRVO -1.1% (Apple reportedly to cut production on iPhone production targets)
- CRUS -1% (Apple reportedly to cut production on iPhone production targets)
- AVGO -0.9% (Apple reportedly to cut production on iPhone production targets)
Analyst comments:
- BRBR -1.4% (downgraded to Hold from Buy at Truist)
Gapping up
In reaction to earnings/guidance:
- SGH +12.8% SAP +5.3% PNFP +2% BLK +1.5% JPM +0.6%
Other news:
- RVNC +10.1% (continues to anticipate FDA approval of DaxibotulinumtoxinA this year)
- ALYA +7.3% (awarded a 3-year contract to accompany a major Quebec government ministry in accelerating its digital transformation agenda)
- VMEO +6.7% (provides metrics for Sept; subscribers increased 14% yr/yr in the month)
- VST +6.5% (announces new $2 bln share repurchase program)
- AVXL +3.5% (Independent Data Safety Monitoring Board for the Company's Phase 2b/3 Alzheimer's disease study of its investigational compound ANAVEX 2-73 has completed its recent pre-planned review of the preliminary Phase 2b/3 study data)
- CMCL +2.8% (reports record gold production in Q3)
- BCYC +2.5% (prices offering of 3240741 ADSs at $54.00 per ADS)
- FIXX +2% (announces pheEDIT Phase 1 clinical trial for HMI-103)
- CRS +1.7% (names new Chairman)
- QCOM +1.7% (approves new $10 bln stock repurchase authorization)
- PEI +1.7% (reports continued strong metrics in traffic sales and collections)
- ESTC +1.5% (expands integrations with Google Cloud)
- DCT +1.4% (announces partnership with Safekeep)
- NXPI +1.2% (names new CFO)
- ANGI +1.1% (reports monthly metrics for Sep)
- TEVA +1% (reports new safety data on treatment with COPAXONE)
Analyst comments:
- PLUG +6.4% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- WEX +1.3% (upgraded to Buy from Neutral at BofA Securities)